NTI 0.00% 7.0¢ neurotech international limited

Rights issue along with positive study results, page-7

  1. 3,516 Posts.
    lightbulb Created with Sketch. 299
    It's only a loss if you crystallise it. How about everyone waits for the results before they spew doom and gloom.

    If the product has been proven by the Carrick's study I would expect that the MANY distribution agreements will see significant increase in demand for units. Revenue will follow and possibly a CR as we enter the FDA trials.

    Why would the company spend a great deal of time and resources establishing distribution networks, relationships in different regions and voluntarily have Mente studied unless they stood by and believed their tech works.

    IMO the results will be better than just good.
    Last edited by stotes: 26/09/17
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.000(0.00%)
Mkt cap ! $64.55M
Open High Low Value Volume
7.1¢ 7.1¢ 6.5¢ $108.7K 1.612M

Buyers (Bids)

No. Vol. Price($)
1 10000 6.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 123991 2
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.